CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
tsDCS+pDCS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07467850
NCT07467850N/ACompleted
CompareCT.gov

Dual Stimulation for Spinal Cord Injury

Spaulding Rehabilitation Hospital·interventional·Posted Mar 12, 2026·Updated Mar 12, 2026

In Brief

A clinical study evaluating tsDCS+pDCS and Low-level laser therapy for Spinal Cord Injuries. Completed, enrolled 8 participants across 1 site.

Detailed Summary

The goal of this Spinal Cord Injury (SCI) Open-Label Clinical Trial is to test the safety and feasibility of the intervention. The study aims to answer whether implementing this intervention on inpatients at a specialized rehabilitation hospital is possible. All participants will receive the intervention and be asked to report side effects and tolerability. Additionally, injury markers for safety and signal recordings to detect changes will be assessed pre- and post-intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Cord Injuries
CountriesUnited States
CollaboratorsPathMaker Neurosystems Inc., Erchonia Corporation

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 12, 2026
Enrollment StartJul 14, 2022
Primary CompletionJul 1, 2024
Study CompletionSep 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 4 months ago

Interventions

tsDCS+pDCSdevice

Pathmaker Neurosystems Inc. "MyoRegulator" trans-spinal and peripheral direct current stimulation.

Low-level laser therapydevice

Erchonia Corp. "Erchonia FX405" low level laser